Cytokinetics Inc. buy Morgan Stanley
Start price
04.08.23
/
50%
€30.20
Target price
04.08.24
€54.39
Performance (%)
67.22%
End price
05.08.24
€50.50
Summary
This prediction ended on 05.08.24 with a price of €50.50. With a performance of 67.22% the BUY prediction by Morgan_Stanley was a big success. Morgan_Stanley has a follow-up prediction for Cytokinetics Inc. where he still thinks Cytokinetics Inc. is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cytokinetics Inc. | 0.000% | 0.000% | 29.854% |
| iShares Core DAX® | -3,99 % | -2,81 % | 4,16 % |
| iShares Nasdaq 100 | 0,35 % | -0,75 % | 9,47 % |
| iShares Nikkei 225® | -3,85 % | 4,23 % | 28,36 % |
| iShares S&P 500 | 0,30 % | 0,38 % | 6,14 % |
Comments by Morgan_Stanley for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $60.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
In the thread Trading Cytokinetics Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Cytokinetics Inc.
Stopped prediction by Morgan_Stanley for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.00
13.02.25
13.02.25
€64.45
13.02.26
13.02.26
35.37%
14.02.26
14.02.26
